AIGEN INVESTMENT MANAGEMENT, LP - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 210 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
AIGEN INVESTMENT MANAGEMENT, LP ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$182,031
-56.5%
19,427
+111.8%
0.03%
+30.8%
Q4 2021$418,0009,1740.03%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
SB INVESTMENT ADVISERS (UK) LTD 22,616,666$284,405,0003.12%
INDUS CAPITAL PARTNERS, LLC 681,936$8,575,0001.68%
Alphabet Inc. 1,666,666$20,958,0001.27%
Temasek Holdings (Private) Ltd 5,499,999$69,162,0000.45%
Board of Trustees of The Leland Stanford Junior University 38,905$490,0000.06%
Baillie Gifford 500,000$6,287,0000.01%
Marshall Wace North America L.P. 74,898$941,0000.01%
Capital International Investors 983,300$12,365,0000.00%
Blackstone Inc. 35,000$440,0000.00%
Tower Research Capital LLC (TRC) 1,908$24,0000.00%
View complete list of VIR BIOTECHNOLOGY INC shareholders